期刊文献+

中医药靶向干预气道非肾上腺素能非胆碱能神经治疗哮喘的研究进展 被引量:5

Research progress of targeted intervention of traditional Chinese medicine in airway non-adrenergic non-cholinergic nerve in the treatment of asthma
下载PDF
导出
摘要 哮喘的病因复杂,发病机制可概括为气道免疫-炎症机制、神经调节机制及其相互作用.气道非肾上腺素能非胆碱能(NANC)神经及其释放的神经递质可通过调节气道平滑肌收缩、黏液分泌、可逆性气道阻塞、气道高反应性干预哮喘发病.神经生长因子通过调节P物质等NANC神经释放的神经激肽,影响NANC神经的可塑性.哮喘在中医辨证为"哮病""喘证".时下有关中医药调控哮喘气道炎症的研究较为详实,而对中医药干预哮喘NANC神经及其释放的神经递质的的报道较为少见.本文就近年来中医药干预NANC神经及其释放的神经递质与相关下游通路、神经生长因子对NANC神经的影响做一简要的综述,以期为临床研究和实验研究开阔思路. The etiology of asthma is complex,and the pathogenesis can be summarized as airway immune-inflammation mechanism,neuromodulation mechanism and their interaction.Airway non-adrenergic non-cholinergic(NANC)nerves and the neurotransmitters they release can interfere with the onset of asthma by regulating airway smooth muscle contraction,mucus secretion,reversible airway obstruction,and airway hyperresponsiveness.Nerve growth factor affects the plasticity of NANC nerve by regulating the neurokinin released by NANC nerve,such as substance P.The syn drome differentiation of asthma in traditional Chinese medicine is"wheezing disease"and"gasp syndrome".Current studies on the regulation of airway inflammation in asthma by traditional Chinese medicine are more detailed,while reports on the intervention of traditional Chinese medicine in the NANC nerve and its neurotransmitters in asthma are rare.In this paper,the intervention of traditional Chinese medicine on the NANC nerve and its neurotransmitters and related downstream pathways,as well as the influence of nerve growth factor on the NANC nerve are briefly reviewed in recent years,in order to broaden the thinking for clinical and experimental studies.
作者 张硕 秦云普 毕明达 封继宏 刘健 ZHANG Shuo;QIN Yunpu;BI Mingda;FENG Jihong;LIU Jian(Department of Respiratory and Critical Care Medicine,the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300150,China;the Graduate School,Tianjin University of Traditional Chinese Medicine,Tianjin 300193,China)
出处 《中国医药导报》 CAS 2020年第16期37-40,共4页 China Medical Herald
基金 国家自然科学基金资助项目(81804026)。
关键词 哮喘 非肾上腺素能胆碱能神经 血管活性肠肽 一氧化氮 P物质 神经生长因子 Asthma Non-adrenergic non-cholinergic nerve Vasoactive intestinal polypeptide Nitric oxide Substance P Nerve growth factor
  • 相关文献

参考文献26

二级参考文献281

共引文献3081

同被引文献127

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部